Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Sharon Y Y LowNurfahanah Bte Syed SulaimanEnrica E K TanLee Ping NgChik Hong KuickKenneth T E ChangPhua Hwee TangRu Xin WongWen Shen LooiDavid C Y LowWan Tew SeowPublished in: BMC cancer (2020)
This study demonstrates higher expression of selected CSF cytokines, in particular CCL2, in metastatic Group 3 and 4 MB patients. Although our results are preliminary, they establish a proof-of-concept basis for continued work in a larger cohort of patients affected by this devastating disease.